Larson TS - Search Results

1

Kidney allograft fibrosis and atrophy early after living donor transplantation.

Cosio FG, Grande JP, Larson TS, Gloor JM, Velosa JA, Textor SC, Griffin MD, Stegall MD. Cosio FG, et al. Among authors: larson ts. Am J Transplant. 2005 May;5(5):1130-6. doi: 10.1111/j.1600-6143.2005.00811.x. Am J Transplant. 2005. PMID: 15816896 Free article.

2

Renal papillary necrosis--a sixteen-year clinical experience.

Griffin MD, Bergstralhn EJ, Larson TS. Griffin MD, et al. Among authors: larson ts. J Am Soc Nephrol. 1995 Aug;6(2):248-56. doi: 10.1681/ASN.V62248. J Am Soc Nephrol. 1995. PMID: 7579092

3

Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs.

Radford MG Jr, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, McCarthy JT. Radford MG Jr, et al. Among authors: larson ts. JAMA. 1996 Aug 14;276(6):466-9. JAMA. 1996. PMID: 8691554

4

The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.

Donadio JV Jr, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. Donadio JV Jr, et al. Among authors: larson ts. J Am Soc Nephrol. 1999 Aug;10(8):1772-7. doi: 10.1681/ASN.V1081772. J Am Soc Nephrol. 1999. PMID: 10446945 Clinical Trial.

5

Pancreas transplantation for the prevention of diabetic nephropathy.

Stegall MD, Larson TS, Kudva YC, Grande JP, Nyberg SL, Prieto M, Velosa JA, Rizza RA. Stegall MD, et al. Among authors: larson ts. Mayo Clin Proc. 2000 Jan;75(1):49-56. doi: 10.4065/75.1.49. Mayo Clin Proc. 2000. PMID: 10630757 Review.

6

Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.

Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Dyck PJ, et al. Among authors: larson ts. Diabetes Care. 2000 Apr;23(4):510-7. doi: 10.2337/diacare.23.4.510. Diabetes Care. 2000. PMID: 10857944

7

Renal physiology in pig-to-baboon xenografts.

Cohen AJ, Larson TS, Dean P, Logan J, Diamond L, McGregor CG, Stegall MD. Cohen AJ, et al. Among authors: larson ts. Transplant Proc. 2001 Feb-Mar;33(1-2):727-8. doi: 10.1016/s0041-1345(00)02226-0. Transplant Proc. 2001. PMID: 11267042 No abstract available.

8

A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy.

Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. Donadio JV Jr, et al. Among authors: larson ts. J Am Soc Nephrol. 2001 Apr;12(4):791-799. doi: 10.1681/ASN.V124791. J Am Soc Nephrol. 2001. PMID: 11274240 Clinical Trial.

9

Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety.

Velosa JA, Larson TS, Gloor JM, Stegall MD. Velosa JA, et al. Among authors: larson ts. Am J Kidney Dis. 2001 Oct;38(4 Suppl 2):S3-S10. doi: 10.1053/ajkd.2001.27504. Am J Kidney Dis. 2001. PMID: 11583938 Clinical Trial.

10

Increased weakness after pancreas and kidney transplantation.

Dyck PJ, Velosa JA, Pach JM, Sterioff S, Larson TS, Norell JE, O'Brien PC, Dyck PJ. Dyck PJ, et al. Among authors: larson ts. Transplantation. 2001 Oct 27;72(8):1403-8. doi: 10.1097/00007890-200110270-00013. Transplantation. 2001. PMID: 11685112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters